Black Diamond Therapeutics, Inc. — All Filings
463 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-117938 | Mar 20, 2026 | — |
| 4 | — | 0002018686-26-000002 | Mar 20, 2026 | — |
| S-8 | FORM S-8 | 0001104659-26-028461 | Mar 16, 2026 | — |
| 10-K | 10-K | 0001701541-26-000009 | Mar 16, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001701541-26-000008 | Mar 16, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-001085 | Feb 17, 2026 | — |
| 4 | — | 0001895913-26-000002 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | — | 0001637054-26-000002 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | — | 0001880385-26-000002 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | — | 0001686295-26-000002 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | — | 0001706847-26-000002 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | 4 | 0001193125-25-319303 | Dec 15, 2025 | Dec 12, 2025 |
| 4 | — | 0002018686-25-000007 | Dec 15, 2025 | Dec 12, 2025 |
| EFFECT | — | 9999999995-25-003511 | Dec 3, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-117975 | Dec 3, 2025 | — |
| S-3 | S-3 | 0001104659-25-111490 | Nov 13, 2025 | — |
| 10-Q | 10-Q | 0001701541-25-000039 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001701541-25-000038 | Nov 6, 2025 | — |
| 4 | 4 | 0001193125-25-211678 | Sep 22, 2025 | Sep 19, 2025 |
| 4 | — | 0002018686-25-000004 | Sep 22, 2025 | Sep 19, 2025 |
| 10-Q | 10-Q | 0001701541-25-000030 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001701541-25-000029 | Aug 7, 2025 | — |
| 4 | 4 | 0000950170-25-088527 | Jun 20, 2025 | — |
| 4 | — | 0001415889-25-017821 | Jun 20, 2025 | — |
| 4 | 4 | 0000950170-25-085676 | Jun 12, 2025 | — |
| 4 | — | 0001415889-25-017058 | Jun 12, 2025 | — |
| 4 | — | 0001415889-25-017056 | Jun 12, 2025 | — |
| 4 | — | 0001415889-25-017053 | Jun 12, 2025 | — |
| 4 | — | 0001415889-25-017050 | Jun 12, 2025 | — |
| 4 | — | 0001415889-25-017048 | Jun 12, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-058893 | Jun 12, 2025 | — |
| 10-Q | 10-Q | 0001701541-25-000022 | May 12, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001701541-25-000021 | May 12, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-001839 | Apr 29, 2025 | — |
| ARS | ARS | 0001104659-25-036343 | Apr 18, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001104659-25-036341 | Apr 18, 2025 | — |
| DEF 14A | DEF 14A | 0001104659-25-036339 | Apr 18, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-043221 | Mar 21, 2025 | — |
| 4 | — | 0001415889-25-008771 | Mar 21, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-026516 | Mar 21, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-026305 | Mar 20, 2025 | Mar 19, 2025 |
| 8-K | FORM 8-K | 0001104659-25-025338 | Mar 19, 2025 | Mar 18, 2025 |
| S-8 | FORM S-8 | 0001104659-25-021373 | Mar 6, 2025 | — |
| 10-K | 10-K | 0001701541-25-000016 | Mar 6, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001701541-25-000014 | Mar 6, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-013934 | Feb 14, 2025 | — |
| 4 | — | 0001415889-25-002494 | Jan 31, 2025 | Jan 30, 2025 |
| 4 | — | 0001415889-25-002493 | Jan 31, 2025 | Jan 30, 2025 |
| 4 | — | 0001415889-25-002492 | Jan 31, 2025 | Jan 30, 2025 |
| 4 | — | 0001415889-25-002489 | Jan 31, 2025 | Jan 30, 2025 |